The discovery of an orally efficacious positive allosteric modulator of the calcium sensing receptor containing a dibenzylamine core
Paul E. Harrington(Amgen (United States)), Christopher Fotsch(Amgen (United States)), Yuhua Yang(Amgen (United States)), Thomas Coulter(Evotec (United Kingdom)), Michael D. Croghan(Amgen (United States)), Minghan Wang(Shanghai Ninth People's Hospital), Andrew S. Tasker(Amgen (United States)), Chiara Ghiron(Evotec (United Kingdom)), Fred D. Lott(Amgen (United States)), Adam J. Davenport(Evotec (United Kingdom)), David J. St. Jean(Amgen (United States)), Steve F. Poon(Amgen (United States)), Jeff D. Reagan(Amgen (United States)), Jeffrey Clarine(Amgen (United States)), Michael Kelly(Commonwealth Scientific and Industrial Research Organisation), Jonathan P. Hutchinson(Evotec (United Kingdom)), Guomin Yao(Amgen (United States)), Kelly Regal(Amgen (United States)), Qingping Zeng(Amgen (United States)), David E. Martin(Phipps Houses), James Davis(Amgen (United States)), Charles M. Henley(Amgen (United States)), Jenny Ying-Lin Lu(Amgen (United States)), Elena Portero-Larragueta(Evotec (United Kingdom)), Sean Morony(Amgen (United States))
Cited by 10
Related Papers
Functional recovery in parkinsonian monkeys treated with GDNF
|Nature|1996|964
The histamine H3 receptor as a therapeutic drug target for CNS disorders
|Drug Discovery Today|2009|181
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats
|Kidney International|2007|136
Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation
|Journal of Medicinal Chemistry|2008|70